![Karl Elmqvist](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karl Elmqvist
Direttore/Membro del Consiglio presso AnaCardio AB
Posizioni attive di Karl Elmqvist
Società | Posizione | Inizio | Fine |
---|---|---|---|
AnaCardio AB
![]() AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Direttore/Membro del Consiglio | 01/09/2022 | - |
Flerie Invest AB
![]() Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investitore di Private Equity | 01/10/2022 | - |
Analista di Private Equity | 01/08/2021 | 01/10/2022 |
Storia della carriera di Karl Elmqvist
Precedenti posizioni note di Karl Elmqvist
Società | Posizione | Inizio | Fine |
---|---|---|---|
Guy's & St Thomas' Charity
![]() Guy's & St Thomas' Charity Services to the Health IndustryHealth Services Guy''s & St Thomas'' Charity operates as an independent, place-based foundation. It works with Guy’s and St Thomas’ NHS Foundation Trust and others to improve the health of people in the London boroughs of Lambeth and Southwark. The company is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 01/07/2020 | 31/08/2021 |
Doctrin AB
![]() Doctrin AB Internet Software/ServicesTechnology Services Doctrin AB offers consultancy services within healthcare sector. It offers digital solutions that enable healthcare providers to prioritize, treat, and follow-up with their patients. The company was founded by Per Eriksson, Ashkan Labaf, Magnus Liungman, and Carslo Lorente in 2016 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 01/09/2019 | 31/05/2020 |
Qvartz AB | Corporate Officer/Principal | 01/04/2018 | 31/05/2018 |
Imperial Consulting, Inc. | Corporate Officer/Principal | 01/01/2016 | 31/03/2016 |
Tetra Pak Holdings AB | Corporate Officer/Principal | 01/07/2015 | 30/09/2015 |
Formazione di Karl Elmqvist
Imperial College London | Undergraduate Degree |
Imperial College Business School | Undergraduate Degree |
Statistiche
Distribuzione geografica
Svezia | 6 |
Regno Unito | 5 |
Posizioni
Corporate Officer/Principal | 4 |
Undergraduate Degree | 2 |
Director/Board Member | 2 |
Settori
Consumer Services | 3 |
Technology Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 7 |
---|---|
Tetra Pak Holdings AB | |
Imperial Consulting, Inc. | |
Qvartz AB | |
Doctrin AB
![]() Doctrin AB Internet Software/ServicesTechnology Services Doctrin AB offers consultancy services within healthcare sector. It offers digital solutions that enable healthcare providers to prioritize, treat, and follow-up with their patients. The company was founded by Per Eriksson, Ashkan Labaf, Magnus Liungman, and Carslo Lorente in 2016 and is headquartered in Stockholm, Sweden. | Technology Services |
AnaCardio AB
![]() AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Health Technology |
Guy's & St Thomas' Charity
![]() Guy's & St Thomas' Charity Services to the Health IndustryHealth Services Guy''s & St Thomas'' Charity operates as an independent, place-based foundation. It works with Guy’s and St Thomas’ NHS Foundation Trust and others to improve the health of people in the London boroughs of Lambeth and Southwark. The company is headquartered in London, the United Kingdom. | Health Services |
Flerie Invest AB
![]() Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Finance |
- Borsa valori
- Insiders
- Karl Elmqvist
- Esperienza